Some Employers Are Offering Free Drugs
By MILT
FREUDENHEIM Published:
February 21, 2007
For years,
employers have been pushing their workers to pay more for health care, raising
premiums and out-of-pocket medical expenses in an effort to save money for the
company and force workers to seek only the most necessary care.
Now some employers are reversing course,
convinced that their pennywise approach does not always reduce long-term costs.
In the most radical of various moves, a number of employers are now giving away
drugs to help workers manage chronic conditions like diabetes, high blood pressure, asthma
and depression.
Major employers
like Marriott
International, Pitney Bowes, the
carpet maker Mohawk Industries
and Maine’s state government have introduced free drug programs to avoid
paying for more expensive treatments down the road.
Companies now recognize that “if you get people’s obesity down, cholesterol down, asthma down, you save a lot of money,” said Uwe E. Reinhardt, a health economist at Princeton University.

Charles Posey, a pharmacist at Mohawk Industries
in East Dublin, Ga., with Peggy Cauley during a consultation at a Mohawk plant.
Despite the Bush
administration’s efforts to promote “consumer directed” health care, many
companies are recognizing the limits to shifting too much of the cost of
medical care to employees. Experience, Professor Reinhardt said, is
contradicting the theory that “patients will be more prudent shoppers for health
care if they ache financially when they ache physically.”
Another motive
for the business world could be to stave off a greater government involvement
in health insurance, now that most presidential candidates and other
politicians are promoting health care reform.
Big drug makers
like Pfizer and Merck, which could benefit
politically and financially from the employer drug programs, are also
supporting the effort.
Richard T.
Clark, the chief executive of Merck, made the political connection in a recent
trade journal article. “If we all don’t do a better job, the private
employer-based market will continue to weaken and the country will move forward
toward rationing of care and greater government control, with greater pressure
for a single-payer model with price controls,” Mr. Clark wrote in the American Journal of Managed Care.
One clear motive is to help workers stay
well, averting expensive emergency room care and hospital stays. As health coverage has grown more
costly, many people have been skimping on care, and millions of Americans are
going without health insurance altogether.
Employers are
reacting to a disturbing trend. As most employer-sponsored health plans have
raised co-payments sharply for drugs in recent years, employer drug spending
has slowed. But total health care spending by employers has nonetheless
continued to rise: 7.7 percent last year, or more than double the general
inflation rate, according to the Kaiser Family Foundation. The free drug
programs are being adopted in hopes of countering the rising costs, taking
their place alongside other steps by some employers that have included opening
or expanding health clinics in their factories and offices, and offering
checkups and medicines at no cost or for a modest co-payment.
Given the millions of Americans who suffer from heart disease, depression, asthma or diabetes
— about one in four working-age adults — the movement toward free drugs and
preventive care has the potential to help many people, said Craig Dolezal, a health
care specialist at Hewitt Associates,
a consulting firm.
Co-payments of
$10 to $20 a prescription have become typical, while the co-pay for some
expensive drugs can be $50 or more for a month’s supply. The new employer
programs are waiving those fees.
For people with
serious health problems, free medicine is an incentive not only to stay with
their prescribed regimens, but also to keep in touch with nurses and
pharmacists who monitor changes in their weight, blood pressure and other vital
signs.
At the Mohawk Industries carpet factory in
Dublin, Ga., about 200 of the 750 employees signed up for free blood pressure
and heart drugs last summer after the company held meetings to describe the
benefits of lowering blood pressure and cholesterol.
Alan
Christianson, Mohawk’s benefits administrator, said that the company recognized
a few years ago that it could eventually face health costs so high that
employees could not afford insurance. “We felt we had to do something about
it,” he said.
Peggy Cauley,
36, who supervises a customer service unit at Mohawk’s factory, said she was 30
pounds overweight and had spent $40 a month on blood pressure and heart drugs
before she started the program.
Now the drugs
are free, and Charles Posey, an independent pharmacist stationed at the plant,
monitors her blood pressure and gives advice on “how to maintain my weight,”
Ms. Cauley said. She has lost 20 pounds, she said, but is “still 10 pounds over
my goal.”
Eastman Chemical,
which is based in Kingsport, Tenn., and has offered free mammograms for its workers and free vaccines
for employees’ children, now also provides free drugs and supplies for
diabetics under its health plan.
The company is
trying “to drive value and to target where care is most needed,” said David H.
Sensibaugh, the director of integrated health.
The state of Maine found that it was
spending more than $20 million a year on treatment for about 2,000 diabetes
patients in the state’s health plan, which covers 40,000 employees, retirees
and dependents.
About half the
diabetics had at least one additional serious problem like heart disease, said
Frank Johnson, the Maine plan’s administrator.
Working with Anthem Blue Cross and Blue
Shield, a unit of Wellpoint, the state has
started offering free drugs and supplies to employees with diabetes who take
part in a face-to-face interview with nurse educators and agree to a year of
follow-up telephone sessions, Mr. Johnson said.
Benefits
executives at dozens of large companies are weighing the initial costs and
potential savings of free co-pay programs and other health-plan incentives at
seminars, including one last week at the Midwest Business Group on Health in
Chicago and another scheduled for next month <>There can be perceived
drawbacks for employers, according to a recent academic article that was
generally favorable toward the programs.
Companies with
high rates of worker turnover may believe that they will not get their share of
the eventual savings from a free drug program, while smaller employers may fear
attracting too many workers with chronic illnesses, according to the article by
Michael E. Chernew, a health care policy professor at Harvard,
and Dr. Allison B. Rosen and Dr. A. Mark Fendrick, both of the University of Michigan.
Their report was
published last month in the online edition of the journal Health Affairs.
Later this year,
a Marriott executive is to make a presentation at the University of Michigan,
where researchers are analyzing Marriott’s move to waive co-payments for
generic drugs related to heart disease, diabetes and asthma.
“We can see in
the preliminary numbers that employees taking part have improved their
compliance,” said Jill Berger, the vice president for health and welfare at
Marriott, which covers 160,000 hotel and resort workers and dependents.
Active Health
Management, a health data technology unit of the Aetna insurance company, has
been helping to identify Marriott workers who are eligible to volunteer for the
heart, diabetes or asthma programs.
Protecting the
privacy of employees is an “enormously important and sensitive issue” in these
programs, said Dr. Lonnie Reisman, Active Health’s chief executive.
“We don’t share
the health plan members’ data with physicians or anyone else, unless a member
explicitly gives permission,” Dr. Reisman said. Only “if we see something that
is a real health issue, we will call the doctor without getting permission,” he
said.
Dr. Reisman said
his company scans records of millions of drug purchases and refills and other
medical claims in search of high-risk patients who are candidates for free
drugs and other incentives to get their health priorities in order.
Perhaps the
oldest free drug program was started 10 years ago with diabetes drugs for city
workers in Ashville, N.C. Since then the city has added free drugs for asthma,
blood pressure, cholesterol problems and depression.
Patients in the
Asheville program agree to meet regularly with pharmacists who advise and
encourage them to take their medicine and adopt healthy habits. The program has
been emulated by more than 30 employers nationwide.
Frank Street, 63, a retired employee of
the tax collectors office of Polk County in Florida**, said he had been getting
six free drugs from the county for diabetes and blood pressure for about two
years.
“At one point,
my blood pressure was so out of whack that they started monitoring it on a
daily basis,” Mr. Street said. The program’s records are managed by Thomson
Medstat, a health care information firm.
Now his blood
pressure is “down to target level,” and he reports once a month to his doctor
and Liz Berndt, the program’s pharmacist.
Without the
county program, his drug co-payments would total $110 a month, Mr. Street said.
As employers grapple
with rising health costs “and we become more aggressive about cost-shifting to
patients,” said Dr. Reisman, the Active Health executive, “it will be important
to have this kind of safety net.”
**Correction: February 22, 2007
Because of
an editing error, a front-page article in some copies yesterday about employer
efforts to provide free drugs to workers with chronic medical conditions
misidentified the state in which one of the employers, Polk County, is located.
It is in Florida, not Georgia.
2/27/07